A citation-based method for searching scientific literature

Paola Monti, Chiara Perfumo, Alessandra Bisio, Yari Ciribilli, Paola Menichini, Debora Russo, David M Umbach, Michael A Resnick, Alberto Inga, Gilberto Fronza. Mol Cancer Res 2011
Times Cited: 48







List of co-cited articles
396 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis.
Shunsuke Kato, Shuang-Yin Han, Wen Liu, Kazunori Otsuka, Hiroyuki Shibata, Ryunosuke Kanamaru, Chikashi Ishioka. Proc Natl Acad Sci U S A 2003
531
35

p53 transactivation and the impact of mutations, cofactors and small molecules using a simplified yeast-based screening system.
Virginia Andreotti, Yari Ciribilli, Paola Monti, Alessandra Bisio, Mattia Lion, Jennifer Jordan, Gilberto Fronza, Paola Menichini, Michael A Resnick, Alberto Inga. PLoS One 2011
37
35

Transcriptional functionality of germ line p53 mutants influences cancer phenotype.
Paola Monti, Yari Ciribilli, Jennifer Jordan, Paola Menichini, David M Umbach, Michael A Resnick, Lucio Luzzatto, Alberto Inga, Gilberto Fronza. Clin Cancer Res 2007
37
32

Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers.
Gaëlle Bougeard, Mariette Renaux-Petel, Jean-Michel Flaman, Camille Charbonnier, Pierre Fermey, Muriel Belotti, Marion Gauthier-Villars, Dominique Stoppa-Lyonnet, Emilie Consolino, Laurence Brugières,[...]. J Clin Oncol 2015
315
22

Li-fraumeni syndrome.
David Malkin. Genes Cancer 2011
231
20

TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data.
Liacine Bouaoun, Dmitriy Sonkin, Maude Ardin, Monica Hollstein, Graham Byrnes, Jiri Zavadil, Magali Olivier. Hum Mutat 2016
400
20

Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database.
Audrey Petitjean, Ewy Mathe, Shunsuke Kato, Chikashi Ishioka, Sean V Tavtigian, Pierre Hainaut, Magali Olivier. Hum Mutat 2007
18

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.
D Malkin, F P Li, L C Strong, J F Fraumeni, C E Nelson, D H Kim, J Kassel, M A Gryka, F Z Bischoff, M A Tainsky. Science 1990
18

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
18

Gain of function of mutant p53 by coaggregation with multiple tumor suppressors.
Jie Xu, Joke Reumers, José R Couceiro, Frederik De Smet, Rodrigo Gallardo, Stanislav Rudyak, Ann Cornelis, Jef Rozenski, Aleksandra Zwolinska, Jean-Christophe Marine,[...]. Nat Chem Biol 2011
322
16

Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome.
Gene A Lang, Tomoo Iwakuma, Young-Ah Suh, Geng Liu, V Ashutosh Rao, John M Parant, Yasmine A Valentin-Vega, Tamara Terzian, Lisa C Caldwell, Louise C Strong,[...]. Cell 2004
771
16

A simple p53 functional assay for screening cell lines, blood, and tumors.
J M Flaman, T Frebourg, V Moreau, F Charbonnier, C Martin, P Chappuis, A P Sappino, I M Limacher, L Bron, J Benhattar. Proc Natl Acad Sci U S A 1995
431
16

Mutant p53: one name, many proteins.
William A Freed-Pastor, Carol Prives. Genes Dev 2012
748
16

Transactivation specificity is conserved among p53 family proteins and depends on a response element sequence code.
Yari Ciribilli, Paola Monti, Alessandra Bisio, H Thien Nguyen, Abdul S Ethayathulla, Ana Ramos, Giorgia Foggetti, Paola Menichini, Daniel Menendez, Michael A Resnick,[...]. Nucleic Acids Res 2013
32
25

Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome.
Kenneth P Olive, David A Tuveson, Zachary C Ruhe, Bob Yin, Nicholas A Willis, Roderick T Bronson, Denise Crowley, Tyler Jacks. Cell 2004
901
14


p63-associated disorders.
Tuula Rinne, Hans G Brunner, Hans van Bokhoven. Cell Cycle 2007
208
14

p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities.
A Yang, M Kaghad, Y Wang, E Gillett, M D Fleming, V Dötsch, N C Andrews, D Caput, F McKeon. Mol Cell 1998
14

Characterization of the p53 mutants ability to inhibit p73 beta transactivation using a yeast-based functional assay.
Paola Monti, Paola Campomenosi, Yari Ciribilli, Raffaella Iannone, Anna Aprile, Alberto Inga, Mitsuhiro Tada, Paola Menichini, Angelo Abbondandolo, Gilberto Fronza. Oncogene 2003
32
21

Tumour p53 mutations exhibit promoter selective dominance over wild type p53.
Paola Monti, Paola Campomenosi, Yari Ciribilli, Raffaella Iannone, Alberto Inga, Angelo Abbondandolo, Michael A Resnick, Gilberto Fronza. Oncogene 2002
50
14

The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis.
Bernard Leroy, Jean Louis Fournier, Chikashi Ishioka, Paola Monti, Alberto Inga, Gilberto Fronza, Thierry Soussi. Nucleic Acids Res 2013
105
14

Mutant p53 in cancer: new functions and therapeutic opportunities.
Patricia A J Muller, Karen H Vousden. Cancer Cell 2014
905
14


When mutants gain new powers: news from the mutant p53 field.
Ran Brosh, Varda Rotter. Nat Rev Cancer 2009
767
12

How many mutant p53 molecules are needed to inactivate a tetramer?
Wan Mui Chan, Wai Yi Siu, Anita Lau, Randy Y C Poon. Mol Cell Biol 2004
137
12

p73 function is inhibited by tumor-derived p53 mutants in mammalian cells.
C J Di Como, C Gaiddon, C Prives. Mol Cell Biol 1999
369
12

p53-family proteins and their regulators: hubs and spokes in tumor suppression.
L Collavin, A Lunardi, G Del Sal. Cell Death Differ 2010
160
12

TP53 mutations in human cancers: origins, consequences, and clinical use.
Magali Olivier, Monica Hollstein, Pierre Hainaut. Cold Spring Harb Perspect Biol 2010
958
12

Simple identification of dominant p53 mutants by a yeast functional assay.
A Inga, S Cresta, P Monti, A Aprile, G Scott, A Abbondandolo, R Iggo, G Fronza. Carcinogenesis 1997
41
14


Differential transactivation by the p53 transcription factor is highly dependent on p53 level and promoter target sequence.
Alberto Inga, Francesca Storici, Thomas A Darden, Michael A Resnick. Mol Cell Biol 2002
152
12

Definition of a consensus binding site for p53.
W S el-Deiry, S E Kern, J A Pietenpol, K W Kinzler, B Vogelstein. Nat Genet 1992
12

Transcriptional control of human p53-regulated genes.
Todd Riley, Eduardo Sontag, Patricia Chen, Arnold Levine. Nat Rev Mol Cell Biol 2008
12

Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers.
M Kaghad, H Bonnet, A Yang, L Creancier, J C Biscan, A Valent, A Minty, P Chalon, J M Lelias, X Dumont,[...]. Cell 1997
12

p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.
P Campomenosi, P Monti, A Aprile, A Abbondandolo, T Frebourg, B Gold, T Crook, A Inga, M A Resnick, R Iggo,[...]. Oncogene 2001
109
12

A cancer family syndrome in twenty-four kindreds.
F P Li, J F Fraumeni, J J Mulvihill, W A Blattner, M G Dreyfus, M A Tucker, R W Miller. Cancer Res 1988
968
12

Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study.
Anita Villani, Uri Tabori, Joshua Schiffman, Adam Shlien, Joseph Beyene, Harriet Druker, Ana Novokmet, Jonathan Finlay, David Malkin. Lancet Oncol 2011
258
12

∆N-P63α and TA-P63α exhibit intrinsic differences in transactivation specificities that depend on distinct features of DNA target sites.
Paola Monti, Yari Ciribilli, Alessandra Bisio, Giorgia Foggetti, Ivan Raimondi, Paola Campomenosi, Paola Menichini, Gilberto Fronza, Alberto Inga. Oncotarget 2014
16
37

Screening patients for heterozygous p53 mutations using a functional assay in yeast.
C Ishioka, T Frebourg, Y X Yan, M Vidal, S H Friend, S Schmidt, R Iggo. Nat Genet 1993
238
12

EEC- and ADULT-associated TP63 mutations exhibit functional heterogeneity toward P63 responsive sequences.
Paola Monti, Debora Russo, Renata Bocciardi, Giorgia Foggetti, Paola Menichini, Maria T Divizia, Margherita Lerone, Claudio Graziano, Anita Wischmeijer, Hector Viadiu,[...]. Hum Mutat 2013
13
46

Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study.
Anita Villani, Ari Shore, Jonathan D Wasserman, Derek Stephens, Raymond H Kim, Harriet Druker, Bailey Gallinger, Anne Naumer, Wendy Kohlmann, Ana Novokmet,[...]. Lancet Oncol 2016
250
12


The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss.
Tamara Terzian, Young-Ah Suh, Tomoo Iwakuma, Sean M Post, Manja Neumann, Gene A Lang, Carolyn S Van Pelt, Guillermina Lozano. Genes Dev 2008
265
10


Structure of p73 DNA-binding domain tetramer modulates p73 transactivation.
Abdul S Ethayathulla, Pui-Wah Tse, Paola Monti, Sonha Nguyen, Alberto Inga, Gilberto Fronza, Hector Viadiu. Proc Natl Acad Sci U S A 2012
39
12

Diversity in DNA recognition by p53 revealed by crystal structures with Hoogsteen base pairs.
Malka Kitayner, Haim Rozenberg, Remo Rohs, Oded Suad, Dov Rabinovich, Barry Honig, Zippora Shakked. Nat Struct Mol Biol 2010
153
10

The coordinated p53 and estrogen receptor cis-regulation at an FLT1 promoter SNP is specific to genotoxic stress and estrogenic compound.
Yari Ciribilli, Virginia Andreotti, Daniel Menendez, Jan-Stephan Langen, Gilbert Schoenfelder, Michael A Resnick, Alberto Inga. PLoS One 2010
24
20

The expanding universe of p53 targets.
Daniel Menendez, Alberto Inga, Michael A Resnick. Nat Rev Cancer 2009
407
10

Drastic effect of germline TP53 missense mutations in Li-Fraumeni patients.
Yasmine Zerdoumi, Juliette Aury-Landas, Catherine Bonaïti-Pellié, Céline Derambure, Richard Sesboüé, Mariette Renaux-Petel, Thierry Frebourg, Gaëlle Bougeard, Jean-Michel Flaman. Hum Mutat 2013
38
13

TP53 mutants in the tower of babel of cancer progression.
Alessandra Bisio, Yari Ciribilli, Gilberto Fronza, Alberto Inga, Paola Monti. Hum Mutat 2014
29
17


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.